Area of research
Genetics · Cancer Research
Research interest
Research interests include Estrogen and related hormone effects, Breast Cancer Treatment Studies, Cancer-related Molecular Pathways, and Cancer Genomics and Diagnostics.
Hepatectomy <i>versus</i> systemic therapy for liver-limited <i>BRAF</i> V600E-mutated colorectal liver metastases: multicentre retrospective study
C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases
Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC
Association of <i>BRAF</i> Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
Genomic Evolution of Breast Cancer Metastasis and Relapse
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial
rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk